Reganon E - Search Results

1

Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A. Martínez-Dolz L, et al. Among authors: reganon e. J Heart Lung Transplant. 2008 Jul;27(7):760-6. doi: 10.1016/j.healun.2008.04.010. Epub 2008 Jun 6. J Heart Lung Transplant. 2008. PMID: 18582806

2

Usefulness of von Willebrand factor in cardiac allograft vasculopathy: preliminary experience.

Chamorro CI, Almenar L, Martínez-Dolz L, Reganon E, Sánchez-Lacuesta E, Villa P, Ten F, Andrés L, Martínez-Sales V, Salvador A. Chamorro CI, et al. Among authors: reganon e. Transplant Proc. 2006 Oct;38(8):2566-8. doi: 10.1016/j.transproceed.2006.08.026. Transplant Proc. 2006. PMID: 17098004

3

Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation.

Sánchez-Soriano RM, Almenar L, Martínez-Dolz L, Reganon E, Martínez-Sales V, Chamorro CI, Vila V, Martín-Pastor J, Villa P, Salvador A. Sánchez-Soriano RM, et al. Among authors: reganon e. Transplant Proc. 2006 Oct;38(8):2569-71. doi: 10.1016/j.transproceed.2006.09.002. Transplant Proc. 2006. PMID: 17098005

4

What is the best biomarker for diagnosis of rejection in heart transplantation?

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Sánchez-Soriano R, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A. Martínez-Dolz L, et al. Among authors: reganon e. Clin Transplant. 2009 Sep-Oct;23(5):672-80. doi: 10.1111/j.1399-0012.2009.01074.x. Epub 2009 Aug 27. Clin Transplant. 2009. PMID: 19712083

5

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

Martínez-Sales V, Vila V, Réganon E, Goberna MA, Ferrando F, Palencia MA, Aznar J. Martínez-Sales V, et al. Among authors: reganon e. Haemostasis. 1998 Nov-Dec;28(6):301-6. doi: 10.1159/000022446. Haemostasis. 1998. PMID: 10461012 Clinical Trial.

6

Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.

Reganon E, Vila V, Ferrando F, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Reganon E, et al. Thromb Haemost. 1999 Nov;82(5):1403-5. Thromb Haemost. 1999. PMID: 10595627

7

Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

Vila V, Martínez-Sales V, Réganon E, Peris E, Perez F, Ruano M, Aznar J. Vila V, et al. Among authors: reganon e. Haematologica. 2001 Jul;86(7):729-34. Haematologica. 2001. PMID: 11454528 Clinical Trial.

8

Fibrinopeptide A release from intraplatelet fibrinogen is related to thrombin platelet activation.

Vila V, Martinez-Sales V, Réganon E, Aznar J. Vila V, et al. Among authors: reganon e. Thromb Res. 1997 May 1;86(3):263-9. doi: 10.1016/s0049-3848(97)00069-8. Thromb Res. 1997. PMID: 9175247 No abstract available.

9

The effect of thrombin on the dynamic exchange between intraplatelet and extraplatelet fibrinogen.

Vila V, Martínez-Sales V, Réganon E, Aznar J. Vila V, et al. Among authors: reganon e. Br J Haematol. 1997 Dec;99(3):548-54. doi: 10.1046/j.1365-2141.1997.4383248.x. Br J Haematol. 1997. PMID: 9401064 Free article.

10

Erythrocyte membrane composition in patients with primary hypercholesterolemia.

Vayá A, Martínez Triguero M, Réganon E, Vila V, Martínez Sales V, Solá E, Hernández Mijares A, Ricart A. Vayá A, et al. Among authors: reganon e. Clin Hemorheol Microcirc. 2008;40(4):289-94. Clin Hemorheol Microcirc. 2008. PMID: 19126991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters